BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15075907)

  • 1. Treatment of carcinoid of the lung.
    Kosmidis PA
    Curr Opin Oncol; 2004 Mar; 16(2):146-9. PubMed ID: 15075907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
    Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
    Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
    Uprety D; Halfdanarson TR; Molina JR; Leventakos K
    Curr Treat Options Oncol; 2020 Aug; 21(11):86. PubMed ID: 32862320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
    Prinzi N; Rossi RE; Proto C; Leuzzi G; Raimondi A; Torchio M; Milione M; Corti F; Colombo E; Prisciandaro M; Cascella T; Spreafico C; Beninato T; Coppa J; Lo Russo G; Di Bartolomeo M; de Braud F; Pusceddu S
    Clin Lung Cancer; 2021 May; 22(3):161-169. PubMed ID: 33618994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary neuroendocrine/carcinoid tumors: a review article.
    Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
    Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung and Thymic Carcinoids.
    Hann CL; Forde PM
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):699-709. PubMed ID: 30098725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced typical and atypical carcinoid tumours of the lung: management recommendations.
    Melosky B
    Curr Oncol; 2018 Jun; 25(Suppl 1):S86-S93. PubMed ID: 29910651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
    Strosberg JR; Choi J; Cantor AB; Kvols LK
    Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary carcinoid tumors].
    Prosch H
    Radiologe; 2017 May; 57(5):397-406. PubMed ID: 28405692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
    Robelin P; Hadoux J; Forestier J; Planchard D; Hervieu V; Berdelou A; Scoazec JY; Valette PJ; Leboulleux S; Ducreux M; Lombard-Bohas C; Baudin E; Walter T
    J Thorac Oncol; 2019 Jun; 14(6):993-1002. PubMed ID: 30771520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D; Yesner R
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Adjuvant Chemotherapy in Pulmonary Carcinoids: An NCDB Analysis.
    Gosain R; Groman A; Yendamuri SS; Iyer R; Mukherjee S
    Anticancer Res; 2019 Dec; 39(12):6835-6842. PubMed ID: 31810950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in pulmonary carcinoid tumors: a review article.
    Hage R; de la Rivière AB; Seldenrijk CA; van den Bosch JM
    Ann Surg Oncol; 2003 Jul; 10(6):697-704. PubMed ID: 12839856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of carcinoid tumors.
    Detterbeck FC
    Ann Thorac Surg; 2010 Mar; 89(3):998-1005. PubMed ID: 20172187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
    Thomas CF; Tazelaar HD; Jett JR
    Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.